Pharma & Biotech

Protagonist Therapeutics Inc. saw its shares close at $58.86 on Friday, registering a decline of 1.37%, despite a significant corporate...

A substantial institutional investor has significantly reduced its stake in Veeva Systems, the specialized life sciences software provider. Despite the...

The biotechnology sector thrives on definitive data and clear signals, yet Ideaya Biosciences currently finds itself at the center of...

The biotechnology sector thrives on breakthrough innovation, and Xencor stands at a pivotal juncture with multiple advanced clinical programs approaching...

Medical technology firm Semler Scientific faces a growing wave of investor litigation following revelations about a long-concealed Department of Justice...

Eli Lilly and Company shares are currently exhibiting a classic technical consolidation pattern, caught between well-defined support and resistance levels....

Shares of German biotechnology firm BioNTech faced renewed pressure on Friday following a media report examining potential COVID-19 vaccine side...

Esperion Therapeutics has captured significant market attention with a remarkable upward surge in its share price. The biopharmaceutical company's recent...

Merck KGaA's recent $3.9 billion acquisition of SpringWorks Therapeutics is demonstrating immediate strategic value, with European regulators granting marketing authorization...

Entrada Therapeutics, once a promising biotech contender, now finds itself navigating turbulent market conditions. Current shareholders are facing substantial erosion...